Reb Wheeler is a transactional attorney and corporate adviser whose practice is focused on mergers and acquisitions, joint ventures, private equity, securities and general corporate matters. He advises corporations, banks and other financial institutions, private equity firms and other clients in a wide range of industries and in many parts of the world.
Reb has extensive experience advising companies and investors in the pharmaceutical, biotech and medical device industries in connection with acquisitions, divestures, licensing transactions and joint ventures and other collaborative development and commercialization transactions, as well as commercial arrangements such as contract manufacturing and distribution agreements and co-promotion agreements. Reb’s life sciences clients range from private, early-stage firms to large multinational pharmaceutical companies.
Reb joined Mayer Brown in 1999 and became a partner in 2008.